• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Pulm Med . Development and validation of a scoring system to predict the mortality of hospitalized patients with SARS-CoV-2 Omicron: a nationwi

tetano

Editor, Senior Moderator
BMC Pulm Med


. 2024 Jul 3;24(1):312.
doi: 10.1186/s12890-024-03131-5. Development and validation of a scoring system to predict the mortality of hospitalized patients with SARS-CoV-2 Omicron: a nationwide, multicentre study

Wanru Guo[SUP] #[/SUP][SUP] 1 [/SUP], Xiaomeng Li[SUP] #[/SUP][SUP] 1 [/SUP], Cheng Ding[SUP] #[/SUP][SUP] 1 [/SUP], Xiahong Dai[SUP] 2 [/SUP], Shuai Wu[SUP] 3 [/SUP], Yunzhen Shi[SUP] 4 [/SUP], Yongjun Jiang[SUP] 5 [/SUP], Yukun Chang[SUP] 5 [/SUP], Zhidan Zhang[SUP] 6 [/SUP], Shiyang Liu[SUP] 7 [/SUP], Lei Ma[SUP] 8 [/SUP], Yu Zhang[SUP] 8 [/SUP], Tong Zhao[SUP] 9 [/SUP], Wenjuan Hu[SUP] 1 [/SUP], Jiafeng Xia[SUP] 1 [/SUP], Yanwan Shangguan[SUP] 10 [/SUP], Kaijin Xu[SUP] 11 [/SUP]



Affiliations
Abstract

Background: The Omicron variant broke out in China at the end of 2022, causing a considerable number of severe cases and even deaths. The study aimed to identify risk factors for death in patients hospitalized with SARS-CoV-2 Omicron infection and to establish a scoring system for predicting mortality.
Methods: 1817 patients were enrolled at eight hospitals in China from December 2022 to May 2023, including 815 patients in the training group and 1002 patients in the validation group. Forty-six clinical and laboratory features were screened using LASSO regression and multivariable logistic regression.
Results: In the training set, 730 patients were discharged and 85 patients died. In the validation set, 918 patients were discharged and 84 patients died. LASSO regression identified age, levels of interleukin (IL) -6, blood urea nitrogen (BUN), lactate dehydrogenase (LDH), and D-dimer; neutrophil count, neutrophil-to-lymphocyte ratio (NLR) as associated with mortality. Multivariable logistic regression analysis showed that older age, IL-6, BUN, LDH and D-dimer were significant independent risk factors. Based on these variables, a scoring system was developed with a sensitivity of 83.6% and a specificity of 83.5% in the training group, and a sensitivity of 79.8% and a sensitivity of 83.0% in the validation group.
Conclusions: A scoring system based on age, IL-6, BUN, LDH and D-dime can help clinicians identify patients with poor prognosis early.

Keywords: COVID-19; Mortality; Multicentre study; SARS-CoV-2 Omicron variant; Scoring system.

 
Back
Top Bottom